Financial Snapshot

Revenue
$59.13M
TTM
Gross Margin
35.7%
TTM
Net Earnings
-$20.34M
TTM
Current Assets
$46.08M
Q3 2024
Current Liabilities
$28.05M
Q3 2024
Current Ratio
164.25%
Q3 2024
Total Assets
$97.45M
Q3 2024
Total Liabilities
$123.8M
Q3 2024
Book Value
-$26.34M
Q3 2024
Cash
$2.840M
Q3 2024
P/E
-0.5759
Nov 29, 2024 EST
Free Cash Flow
-$15.52M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Revenue $56.83M $74.78M $92.97M $102.0M $90.40M $97.00M $99.10M $99.60M $100.2M $104.9M $91.20M $82.50M $77.90M $89.60M $125.9M $140.1M $143.6M $118.7M $98.60M $80.00M $65.70M $52.00M $37.10M $29.70M $26.10M $23.20M $17.80M $6.800M $10.00M
YoY Change -24.0% -19.56% -8.86% 12.83% -6.8% -2.12% -0.5% -0.6% -4.48% 15.02% 10.55% 5.91% -13.06% -28.83% -10.14% -2.44% 20.98% 20.39% 23.25% 21.77% 26.35% 40.16% 24.92% 13.79% 12.5% 30.34% 161.76% -32.0% 96.08%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Revenue $56.83M $74.78M $92.97M $102.0M $90.40M $97.00M $99.10M $99.60M $100.2M $104.9M $91.20M $82.50M $77.90M $89.60M $125.9M $140.1M $143.6M $118.7M $98.60M $80.00M $65.70M $52.00M $37.10M $29.70M $26.10M $23.20M $17.80M $6.800M $10.00M
Cost Of Revenue $37.38M $52.73M $54.89M $53.40M $52.30M $55.60M $57.30M $56.10M $53.70M $55.50M $46.00M $40.30M $37.80M $45.70M $68.90M $77.60M $88.40M $67.90M $51.40M $40.00M $32.90M $25.70M $18.10M $15.40M $14.50M $15.20M $12.10M $5.000M $8.000M
Gross Profit $19.45M $22.05M $38.08M $48.60M $38.10M $41.40M $41.90M $43.50M $46.50M $49.40M $45.20M $42.30M $40.10M $43.90M $57.00M $62.50M $55.20M $50.80M $47.20M $40.00M $32.80M $26.30M $19.00M $14.30M $11.60M $8.000M $5.800M $1.800M $2.000M
Gross Profit Margin 34.22% 29.48% 40.96% 47.65% 42.15% 42.68% 42.28% 43.67% 46.41% 47.09% 49.56% 51.27% 51.48% 49.0% 45.27% 44.61% 38.44% 42.8% 47.87% 50.0% 49.92% 50.58% 51.21% 48.15% 44.44% 34.48% 32.58% 26.47% 20.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Selling, General & Admin $31.15M $29.17M $24.68M $26.10M $30.30M $26.70M $32.20M $30.40M $28.20M $30.10M $33.10M $22.40M $22.00M $26.90M $36.00M $47.90M $51.10M $42.50M $34.70M $29.30M $16.70M $15.20M $9.600M $5.200M $4.000M $2.500M $3.500M $1.400M $2.300M
YoY Change 6.81% 18.16% -5.43% -13.86% 13.48% -17.08% 5.92% 7.8% -6.31% -9.06% 47.77% 1.82% -18.22% -25.28% -24.84% -6.26% 20.24% 22.48% 18.43% 75.45% 9.87% 58.33% 84.62% 30.0% 60.0% -28.57% 150.0% -39.13% 0.0%
% of Gross Profit 160.16% 132.28% 64.82% 53.7% 79.53% 64.49% 76.85% 69.89% 60.65% 60.93% 73.23% 52.96% 54.86% 61.28% 63.16% 76.64% 92.57% 83.66% 73.52% 73.25% 50.91% 57.79% 50.53% 36.36% 34.48% 31.25% 60.34% 77.78% 115.0%
Research & Development $4.379M $4.138M $4.497M $5.100M $5.300M $5.300M $5.000M $4.600M $5.000M $4.200M $3.500M $3.000M $3.200M $4.600M $7.300M $7.500M $6.700M $6.700M $6.100M $4.700M $5.200M $4.500M $2.800M $2.700M $2.400M $2.600M $1.900M $1.400M $1.500M
YoY Change 5.82% -7.98% -11.82% -3.77% 0.0% 6.0% 8.7% -8.0% 19.05% 20.0% 16.67% -6.25% -30.43% -36.99% -2.67% 11.94% 0.0% 9.84% 29.79% -9.62% 15.56% 60.71% 3.7% 12.5% -7.69% 36.84% 35.71% -6.67% 50.0%
% of Gross Profit 22.51% 18.77% 11.81% 10.49% 13.91% 12.8% 11.93% 10.57% 10.75% 8.5% 7.74% 7.09% 7.98% 10.48% 12.81% 12.0% 12.14% 13.19% 12.92% 11.75% 15.85% 17.11% 14.74% 18.88% 20.69% 32.5% 32.76% 77.78% 75.0%
Depreciation & Amortization $1.777M $2.333M $2.744M $3.070M $4.900M $4.130M $5.200M $6.130M $5.640M $4.500M $3.590M $2.830M $2.600M $2.820M $3.750M $8.050M $7.760M $6.430M $4.230M $2.740M $2.220M $3.500M $2.880M $1.960M $1.510M $750.0K $470.0K $180.0K
YoY Change -23.83% -14.98% -10.62% -37.35% 18.64% -20.58% -15.17% 8.69% 25.33% 25.35% 26.86% 8.85% -7.8% -24.8% -53.42% 3.74% 20.68% 52.01% 54.38% 23.42% -36.57% 21.53% 46.94% 29.8% 101.33% 59.57% 161.11%
% of Gross Profit 9.14% 10.58% 7.21% 6.32% 12.86% 9.98% 12.41% 14.09% 12.13% 9.11% 7.94% 6.69% 6.48% 6.42% 6.58% 12.88% 14.06% 12.66% 8.96% 6.85% 6.77% 13.31% 15.16% 13.71% 13.02% 9.38% 8.1% 10.0%
Operating Expenses $35.53M $32.96M $29.18M $32.60M $37.90M $34.80M $37.70M $35.20M $33.00M $33.90M $36.20M $25.00M $24.40M $29.90M $42.90M $54.20M $57.40M $48.80M $40.50M $33.80M $23.10M $19.70M $12.30M $7.800M $6.400M $5.000M $4.500M $2.200M $2.900M
YoY Change 7.8% 12.97% -10.5% -13.98% 8.91% -7.69% 7.1% 6.67% -2.65% -6.35% 44.8% 2.46% -18.39% -30.3% -20.85% -5.57% 17.62% 20.49% 19.82% 46.32% 17.26% 60.16% 57.69% 21.88% 28.0% 11.11% 104.55% -24.14% 16.0%
Operating Profit -$16.08M -$10.91M $8.901M $16.00M $200.0K $6.600M $4.200M $8.300M $13.50M $15.50M $9.000M $17.30M $15.70M $14.00M $14.10M $8.300M -$2.200M $2.000M $6.700M $6.200M $9.700M $6.600M $6.700M $6.500M $5.200M $3.000M $1.300M -$400.0K -$900.0K
YoY Change 47.36% -222.6% -44.37% 7900.0% -96.97% 57.14% -49.4% -38.52% -12.9% 72.22% -47.98% 10.19% 12.14% -0.71% 69.88% -477.27% -210.0% -70.15% 8.06% -36.08% 46.97% -1.49% 3.08% 25.0% 73.33% 130.77% -425.0% -55.56% -55.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Interest Expense -$9.882M -$24.44M -$7.094M -$6.700M -$6.100M -$4.300M -$4.600M -$4.600M -$3.600M $0.00 $1.200M $2.200M $2.400M $900.0K -$1.200M -$2.100M -$2.700M -$1.500M -$700.0K -$500.0K -$1.700M -$900.0K -$700.0K -$300.0K -$700.0K -$400.0K $0.00 $300.0K $100.0K
YoY Change -59.57% 244.54% 5.88% 9.84% 41.86% -6.52% 0.0% 27.78% -100.0% -45.45% -8.33% 166.67% -175.0% -42.86% -22.22% 80.0% 114.29% 40.0% -70.59% 88.89% 28.57% 133.33% -57.14% 75.0% -100.0% 200.0% -80.0%
% of Operating Profit -79.7% -41.88% -3050.0% -65.15% -109.52% -55.42% -26.67% 0.0% 13.33% 12.72% 15.29% 6.43% -8.51% -25.3% -75.0% -10.45% -8.06% -17.53% -13.64% -10.45% -4.62% -13.46% -13.33% 0.0%
Other Income/Expense, Net $1.171M $303.0K $1.220M $0.00 $200.0K $1.400M $2.400M $2.300M $13.00M $0.00
YoY Change 286.47% -75.16% -100.0% -85.71% -41.67% 4.35% -82.31%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Pretax Income -$36.93M -$41.19M $751.0K -$6.600M -$30.00M -$23.20M -$39.90M -$42.10M $22.90M $15.40M $10.20M $19.40M $18.20M $61.40M $12.90M -$81.70M -$32.10M $500.0K $6.000M $5.700M $8.000M $5.700M $2.400M $4.900M $4.900M $2.600M $1.300M -$800.0K -$800.0K
YoY Change -10.36% -5585.22% -111.38% -78.0% 29.31% -41.85% -5.23% -283.84% 48.7% 50.98% -47.42% 6.59% -70.36% 375.97% -115.79% 154.52% -6520.0% -91.67% 5.26% -28.75% 40.35% 137.5% -51.02% 0.0% 88.46% 100.0% -262.5% 0.0% -75.0%
Income Tax -$59.00K -$192.0K -$178.0K -$600.0K -$1.000M -$500.0K -$2.000M -$3.600M $800.0K $500.0K $600.0K $2.000M $2.600M $900.0K $1.100M -$7.800M $6.600M -$5.600M $700.0K $0.00 $2.200M $800.0K $0.00 $100.0K $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income -23.7% 3.49% 3.25% 5.88% 10.31% 14.29% 1.47% 8.53% -1120.0% 11.67% 0.0% 27.5% 14.04% 0.0% 2.04% 0.0% 0.0% 0.0%
Net Earnings -$36.87M -$41.01M $875.0K -$6.400M -$28.90M -$22.10M -$40.30M -$100.6M $21.80M $17.20M $9.600M $17.30M $15.60M $60.40M $11.80M -$73.90M -$38.70M $6.100M $5.300M $5.700M $5.100M $5.000M $700.0K $1.700M $1.000M $1.600M -$1.300M -$2.600M -$2.400M
YoY Change -10.1% -4786.74% -113.67% -77.85% 30.77% -45.16% -59.94% -561.47% 26.74% 79.17% -44.51% 10.9% -74.17% 411.86% -115.97% 90.96% -734.43% 15.09% -7.02% 11.76% 2.0% 614.29% -58.82% 70.0% -37.5% -223.08% -50.0% 8.33% -33.33%
Net Earnings / Revenue -64.87% -54.84% 0.94% -6.27% -31.97% -22.78% -40.67% -101.0% 21.76% 16.4% 10.53% 20.97% 20.03% 67.41% 9.37% -52.75% -26.95% 5.14% 5.38% 7.13% 7.76% 9.62% 1.89% 5.72% 3.83% 6.9% -7.3% -38.24% -24.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.15 -$0.49 $10.47K -$76.56K -$345.7K -$264.4K -$465.9K -$1.095M $198.9K $181.2K $102.5K $192.7K $175.5K $696.7K $140.8K -$907.9K -$509.2K $84.60K $80.67K $87.02K $100.8K $117.6K $17.03K $41.98K $34.48K $60.61K -$68.06K -$161.5K -$216.2K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Cash & Short-Term Investments $3.691M $6.578M $25.91M $27.30M $16.40M $30.30M $57.60M $77.10M $102.0M $9.100M $22.30M $74.90M $71.10M $58.00M $6.100M $5.200M $8.700M $2.800M $9.900M $15.10M $20.60M $5.800M $5.300M $4.300M $3.100M $1.400M $4.300M
YoY Change -43.89% -74.61% -5.09% 66.46% -45.87% -47.4% -25.29% -24.41% 1020.88% -59.19% -70.23% 5.34% 22.59% 850.82% 17.31% -40.23% 210.71% -71.72% -34.44% -26.7% 255.17% 9.43% 23.26% 38.71% 121.43% -67.44%
Cash & Equivalents $3.691M $6.578M $30.30M $57.60M $77.10M $2.800M $9.900M $15.10M $20.60M $5.800M $5.300M $4.300M $3.100M $1.300M $2.800M
Short-Term Investments $0.00 $3.120M $3.100M $10.10M $94.70M $1.900M $13.30M $63.50M $67.90M $55.60M $1.400M $2.000M $4.500M $0.00 $100.0K $1.400M
Other Short-Term Assets $2.409M $1.932M $1.945M $1.200M $600.0K $5.500M $13.10M $1.800M $700.0K $1.900M $15.50M $9.000M $7.100M $2.100M $2.200M $2.000M $3.300M
YoY Change 24.69% -0.67% 62.08% 100.0% 627.78% 157.14% -63.16% -87.74% 72.22% 26.76% -4.55% 10.0% -39.39%
Inventory $19.93M $22.50M $29.12M $30.20M $32.00M $30.40M $32.80M $32.60M $35.10M $33.50M $29.70M $20.80M $19.80M $17.60M $39.20M $42.30M $44.40M $45.60M $36.50M $37.50M $30.60M $20.90M $16.30M $14.40M $9.500M $10.00M $3.700M
Prepaid Expenses
Receivables $13.90M $15.75M $14.03M $21.20M $20.10M $24.40M $20.70M $22.60M $19.50M $20.30M $19.80M $12.60M $10.70M $11.80M $20.10M $25.00M $23.10M $32.70M $20.90M $13.30M $5.000M $4.200M $4.000M $4.200M
Other Receivables $1.516M $1.834M $1.681M $3.400M $2.300M $1.600M $1.500M $1.200M $1.200M $6.000M $5.000M $2.200M $13.40M $800.0K $1.300M $2.000M $1.700M $300.0K $600.0K $900.0K $800.0K $800.0K $800.0K $400.0K
Total Short-Term Assets $39.04M $46.67M $72.69M $83.30M $71.40M $86.70M $112.6M $133.5M $163.2M $68.90M $76.70M $110.5M $115.0M $101.3M $68.40M $75.20M $79.80M $96.90M $76.90M $74.00M $65.00M $39.30M $29.30M $26.70M $19.80M $18.10M $15.80M
YoY Change -16.34% -35.8% -12.74% 16.67% -17.65% -23.0% -15.66% -18.2% 136.87% -10.17% -30.59% -3.91% 13.52% 48.1% -9.04% -5.76% -17.65% 26.01% 3.92% 13.85% 65.39% 34.13% 9.74% 34.85% 9.39% 14.56%
Property, Plant & Equipment $1.892M $5.682M $5.918M $8.500M $9.300M $5.400M $5.800M $13.40M $20.70M $17.90M $13.00M $8.900M $7.600M $6.000M $12.20M $11.90M $26.40M $22.30M $19.20M $16.00M $13.70M $9.900M $6.000M $5.500M $4.700M $8.400M $5.800M
YoY Change -66.7% -3.99% -30.38% -8.6% 72.22% -6.9% -56.72% -35.27% 15.64% 37.69% 46.07% 17.11% 26.67% -50.82% 2.52% -54.92% 18.39% 16.15% 20.0% 16.79% 38.38% 65.0% 9.09% 17.02% -44.05% 44.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00 $1.100M $1.400M $1.300M $0.00 $600.0K $2.600M
YoY Change -100.0% -21.43% 7.69% -100.0% -76.92%
Other Assets $2.232M $4.485M $4.157M $4.400M $6.300M $6.300M $9.500M $15.40M $17.60M $11.00M $8.200M $5.000M $3.500M $15.90M $5.900M $3.200M $4.100M $8.200M $3.300M $2.500M $600.0K $0.00
YoY Change -50.23% 7.89% -5.52% -30.16% 0.0% -33.68% -38.31% -12.5% 60.0% 34.15% 64.0% 42.86% -77.99% 169.49% 84.38% -21.95% -50.0% 148.48% 32.0% 316.67%
Total Long-Term Assets $20.39M $45.44M $46.21M $47.10M $59.70M $64.50M $80.00M $116.1M $200.5M $173.9M $149.8M $86.90M $56.50M $59.60M $64.00M $54.30M $136.2M $152.2M $107.7M $82.00M $53.10M $50.50M $47.70M $40.50M $25.20M $26.90M $8.800M
YoY Change -55.11% -1.67% -1.9% -21.11% -7.44% -19.38% -31.09% -42.09% 15.3% 16.09% 72.38% 53.81% -5.2% -6.88% 17.86% -60.13% -10.51% 41.32% 31.34% 54.43% 5.15% 5.87% 17.78% 60.71% -6.32% 205.68%
Total Assets $59.44M $92.10M $118.9M $130.4M $131.1M $151.2M $192.6M $249.6M $363.7M $242.8M $226.5M $197.4M $171.5M $160.9M $132.4M $129.5M $216.0M $249.1M $184.6M $156.0M $118.1M $89.80M $77.00M $67.20M $45.00M $45.00M $24.60M
YoY Change
Accounts Payable $14.50M $17.05M $6.794M $7.100M $7.800M $17.30M $20.80M $25.00M $8.300M $9.500M $8.200M $4.500M $3.800M $3.300M $3.700M $11.60M $8.500M $20.50M $12.80M $8.600M $19.40M $18.90M $12.60M $1.500M $2.400M $2.600M $3.700M
YoY Change -14.98% 150.97% -4.31% -8.97% -54.91% -16.83% -16.8% 201.2% -12.63% 15.85% 82.22% 18.42% 15.15% -10.81% -68.1% 36.47% -58.54% 60.16% 48.84% -55.67% 2.65% 50.0% 740.0% -37.5% -7.69% -29.73%
Accrued Expenses $8.067M $9.056M $8.123M $9.900M $8.800M $9.800M $11.40M $9.900M $7.000M $7.500M $7.500M $7.800M $9.500M $14.90M $3.900M $3.200M $4.000M $2.600M
YoY Change -10.92% 11.49% -17.95% 12.5% -14.04% 15.15% 41.43% -6.67% 0.0% -3.85% -17.89% -36.24% 21.88% -20.0% 53.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $2.900M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.800M $7.200M $7.000M $0.00 $0.00 $0.00 $1.000M $0.00 $400.0K $0.00
YoY Change -100.0% -100.0% -75.0% 2.86% -100.0% -100.0%
Long-Term Debt Due $210.0K $210.0K $85.29M $2.200M $2.400M $300.0K $100.0K $200.0K $12.60M $12.70M $15.80M $10.40M $7.700M $4.100M $2.900M $4.300M $4.400M $200.0K
YoY Change 0.0% -99.75% 3776.91% -8.33% -50.0% -98.41% -0.79% -19.62% 51.92% 35.06% 87.8% -32.56% -2.27% 2100.0%
Total Short-Term Liabilities $15.04M $17.34M $100.5M $27.10M $19.40M $17.60M $21.20M $25.30M $20.10M $22.10M $21.00M $13.00M $13.30M $12.30M $25.60M $35.70M $43.50M $35.90M $31.90M $20.50M $20.30M $19.20M $12.70M $9.900M $14.20M $18.10M $8.800M
YoY Change -13.29% -82.75% 270.82% 39.69% 10.23% -16.98% -16.21% 25.87% -9.05% 5.24% 61.54% -2.26% 8.13% -51.95% -28.29% -17.93% 21.17% 12.54% 55.61% 0.99% 5.73% 51.18% 28.28% -30.28% -21.55% 105.68%
Long-Term Debt $54.65M $58.05M $13.87M $99.30M $99.80M $81.60M $94.80M $96.50M $92.60M $0.00 $0.00 $0.00 $0.00 $100.0K $19.20M $23.50M $26.30M $33.10M $12.20M $12.90M $17.40M $7.700M $7.800M $2.300M $8.100M $6.900M $6.700M
YoY Change -5.85% 318.66% -86.04% -0.5% 22.3% -13.92% -1.76% 4.21% -100.0% -99.48% -18.3% -10.65% -20.54% 171.31% -5.43% -25.86% 125.97% -1.28% 239.13% -71.6% 17.39% 2.99%
Other Long-Term Liabilities $11.40M $13.84M $0.00 $1.400M $0.00 $500.0K $500.0K $700.0K $12.30M $2.400M $4.600M $4.300M $0.00 $0.00 $100.0K $100.0K $100.0K $3.400M $200.0K $200.0K $200.0K $0.00 $5.400M $2.000M
YoY Change -17.62% -100.0% -100.0% 0.0% -28.57% -94.31% 412.5% -47.83% 6.98% -100.0% 0.0% 0.0% -97.06% 1600.0% 0.0% 0.0% -100.0% 170.0%
Total Long-Term Liabilities $66.05M $71.88M $13.87M $100.7M $99.80M $82.10M $95.30M $97.20M $104.9M $2.400M $4.600M $4.300M $0.00 $100.0K $19.30M $23.60M $26.40M $36.50M $12.40M $13.10M $17.60M $7.700M $7.800M $2.300M $8.100M $12.30M $8.700M
YoY Change -8.12% 418.45% -86.23% 0.9% 21.56% -13.85% -1.95% -7.34% 4270.83% -47.83% 6.98% -100.0% -99.48% -18.22% -10.61% -27.67% 194.35% -5.34% -25.57% 128.57% -1.28% 239.13% -71.6% -34.15% 41.38%
Total Liabilities $83.38M $94.28M $119.2M $132.6M $126.4M $107.2M $127.4M $140.9M $149.8M $45.90M $43.50M $28.00M $20.20M $19.60M $53.10M $63.60M $79.10M $81.90M $51.00M $37.10M $37.80M $27.30M $20.80M $12.50M $22.10M $30.40M $17.50M
YoY Change -11.56% -20.92% -10.1% 4.91% 17.91% -15.86% -9.58% -5.94% 226.36% 5.52% 55.36% 38.61% 3.06% -63.09% -16.51% -19.6% -3.42% 60.59% 37.47% -1.85% 38.46% 31.25% 66.4% -43.44% -27.3% 73.71%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $11.712 Million

About TRINITY BIOTECH PLC

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The firm is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The firm develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. The company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company, through EpiCapture Limited, is also developing a non-invasive test for monitoring the risk of aggressive prostate cancer. The firm sells its products direct in the United States and through a network of international distributors.

Industry: In Vitro & In Vivo Diagnostic Substances Peers: Medtronic plc STERIS plc